A detailed history of Powers Advisory Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Powers Advisory Group, LLC holds 2,367 shares of LLY stock, worth $1.77 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
2,367
Previous 2,296 3.09%
Holding current value
$1.77 Million
Previous $2.08 Million 0.91%
% of portfolio
1.05%
Previous 1.13%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$772.14 - $960.02 $54,821 - $68,161
71 Added 3.09%
2,367 $2.1 Million
Q2 2024

Jul 24, 2024

BUY
$724.87 - $909.04 $5,798 - $7,272
8 Added 0.35%
2,296 $2.08 Million
Q1 2024

Apr 19, 2024

BUY
$592.2 - $792.28 $34,347 - $45,952
58 Added 2.6%
2,288 $1.78 Million
Q4 2023

Jan 17, 2024

SELL
$525.19 - $619.13 $568,255 - $669,898
-1,082 Reduced 32.67%
2,230 $1.3 Million
Q3 2023

Oct 18, 2023

SELL
$434.7 - $599.3 $103,023 - $142,034
-237 Reduced 6.68%
3,312 $1.78 Million
Q2 2023

Jul 20, 2023

BUY
$350.74 - $468.98 $1,052 - $1,406
3 Added 0.08%
3,549 $1.66 Million
Q1 2023

Apr 13, 2023

SELL
$310.63 - $364.82 $1,553 - $1,824
-5 Reduced 0.14%
3,546 $1.22 Million
Q4 2022

Jan 20, 2023

SELL
$321.55 - $374.67 $100,323 - $116,897
-312 Reduced 8.08%
3,551 $0
Q3 2022

Oct 14, 2022

BUY
$296.48 - $337.87 $2,371 - $2,702
8 Added 0.21%
3,863 $1.25 Million
Q2 2022

Jul 19, 2022

SELL
$278.73 - $327.27 $39,300 - $46,145
-141 Reduced 3.53%
3,855 $1.25 Million
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $1,173 - $1,458
-5 Reduced 0.12%
3,996 $1.14 Million
Q4 2021

May 06, 2022

BUY
$224.85 - $279.04 $899,624 - $1.12 Million
4,001 New
4,001 $1.11 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Powers Advisory Group, LLC Portfolio

Follow Powers Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Powers Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Powers Advisory Group, LLC with notifications on news.